Page 130 - 《中国药房》2025年22期

合物的研究新进展[J]. 中国野生植物资源，2017，36（3）： NF-κB pathways[J]. Zhejiang Univ Sci B，2021，22（9）：
50-52，77. 782-790.
[16] ELUARD B，THIEBLEMONT C，BAUD V. NF-κB in the [26] CHE Y，WANG J N，YUAN Z Y，et al. The therapeutic ef‐
new era of cancer therapy[J]. Trends Cancer，2020，6（8）： fects of longikaurin A，a natural ent-kauranoid，in esopha‐
677-687. geal squamous cell carcinoma depend on ROS accumula‐
[17] ORECCHIONI M，GHOSHEH Y，PRAMOD A B，et al. tion and JNK/p38 MAPK activation[J]. Toxicol Lett，
Macrophage polarization：different gene signatures in M1 2017，280：106-115.
（LPS+）vs. classically and M2（LPS－）vs. alternatively [27] GUO L S，CHEN J，WANG Q Y，et al. Oridonin enhances
activated macrophages[J]. Front Immunol，2019，10：1084. γ-globin expression in erythroid precursors from patients
[18] LIU M R，ZOU G N，LU M Y，et al. Mechanism of Rab‐ with β-thalassemia via activation of p38 MAPK signaling
dosia rubescens extract against gastric cancer microenvi‐ [J]. Mol Med Rep，2020，21（2）：909-917.
ronment by SIRT1/NF-κB/p53 pathway and promoting [28] DING C Y，ZHANG Y S，CHEN H J，et al. Novel
tumor-associated macrophage polarization[J]. J Ethnophar‐ nitrogen-enriched oridonin analogues with thiazole-fused
macol，2025，349：119935. A-ring：protecting group-free synthesis，enhanced antican‐
[19] 覃乐，陈勇，黄桂东，等. 三叶香茶菜提取物对肝星状细 cer profile，and improved aqueous solubility[J]. J Med
胞和肝细胞TLR4/NF-κB/NLRP3通路的影响[J]. 中国药 Chem，2013，56（12）：5048-5058.
房，2022，33（20）：2448-2453. [29] LI X，ZHANG C T，MA W，et al. Oridonin：a review of its
[20] HUANG G D，ZHOU Z P，PANG Z，et al. Effect of Iso‐ pharmacology，pharmacokinetics and toxicity[J]. Front
don ternifolius-medicated serum on hepatic stellate cells Pharmacol，2021，12：645824.
based on TLR4/NF-κB/NLRP3 signaling pathway[J]. [30] DENG T H，WU J P，CHENG H B，et al. Research pro-
Zhongguo Zhong Yao Za Zhi，2023，48（14）：3913-3921. gress and molecular mechanism of oridonin in the treat‐
[21] MUHAMMAD YUSOFF F，WONG K K，MOHD ment of malignant melanoma[J]. Front Oncol，2025，15：
REDZWAN N. Th1，Th2，and Th17 cytokines in systemic 1606325.
lupus erythematosus[J]. Autoimmunity， 2020，53（1）：8-20. [31] XU W，SUN J，ZHANG T T，et al. Pharmacokinetic be‐
[22] LU Y，CHEN B，SONG J H，et al. Eriocalyxin B amelio‐ haviors and oral bioavailability of oridonin in rat plasma
rates experimental autoimmune encephalomyelitis by sup‐ [J]. Acta Pharmacol Sin，2006，27（12）：1642-1646.
pressing Th1 and Th17 cells[J]. Proc Natl Acad Sci USA， [32] PENG K Z，KE Y，ZHAO Q，et al. OP16，a novel ent-
2013，110（6）：2258-2263. kaurene diterpenoid，potentiates the antitumor effect of ra‐
[23] GUO J F，CHEN T，MA Z Y，et al. Oridonin inhibits 4T1 pamycin by inhibiting rapamycin-induced feedback activa‐
tumor growth by suppressing Treg differentiation via TGF- tion of Akt signaling in esophageal squamous cell carci‐
β receptor[J]. Int Immunopharmacol，2020，88：106831. noma[J]. Biochem Pharmacol，2017，140：16-27.
[24] NAJAR M，BOUHTIT F，RAHMANI S，et al. The immu‐ [33] MIRANDA R S，DE JESUS B D S M，DA SILVA LUIZ S
nogenic profile and immunomodulatory function of me- R，et al. Antiinflammatory activity of natural triterpenes：
senchymal stromal/stem cells in the presence of Ptychotis an overview from 2006 to 2021[J]. Phytother Res，2022，
verticillata[J]. Heliyon，2024，10（3）：e24822. 36（4）：1459-1506.
[25] ZHANG W，KAZEEM B B，YANG H T，et al. Aeromonas （收稿日期：2025-07-09 修回日期：2025-10-28）
sobria regulates proinflammatory immune response in （编辑：邹丽娟）
mouse macrophages via activating the MAPK，Akt，and

· 2872 · China Pharmacy 2025 Vol. 36 No. 22 中国药房 2025年第36卷第22期